Abstract
Purpose
Radiofrequency ablation (RFA) effectively treats esophageal high-grade dysplasia, but its efficacy in treating anal canal high-grade squamous intraepithelial lesions (HSILs) is unsubstantiated. This prospective study assessed the safety and efficacy of applying hemi-circumferential RFA to anal canal HSIL.
Methods
Twenty-one HIV-negative participants with HSIL occupying ≤ half the anal canal circumference were treated with hemi-circumferential anal canal RFA. Participants were assessed every 3 months for 12 months with high-resolution anoscopy; recurrence in the treatment zone was re-treated with focal RFA.
Results
Twenty-one participants with a mean of 1.7 lesions (range 1–4) enrolled and completed the trial. Six (29 %) participants had recurrent HSIL within the treated hemi-circumference within 1 year. Four participants (19 %) had persistence of an index lesion at 3 months. One (2.9 %) index HSIL persisted again at 12 months. No participants had more than two RFA treatments. KM curve-predicted HSIL-free survival within the treatment zone at 1 year was 76 % (95 % CI 52–89 %). Comparing the first 7 and last 14 participants, the predicted 1-year HSIL-free survivals are 43 % (95 % CI 10–73 %) and 93 % (95 % CI 59–99 %), respectively (p = 0.008), suggesting a learning curve with the treating physician. Multivariable analysis showed decreased recurrence in the last 14 participants (HR 0.02; 95 % CI 0.001–0.63) while increasing BMI increased recurrence (HR 1.43, 95 % CI 1.01–2.01). No participants had device or procedure-related serious adverse events, anal stricture, or heavy bleeding.
Conclusions
Hemi-circumferential RFA yielded a high rate of anal HSIL eradication in HIV-negative patients at 1 year with minimal adverse events. Lesion persistence was probably related to incomplete initial ablation.
Similar content being viewed by others
References
American Cancer Society. Available at: http://www.cancer.org/cancer/analcancer/detailedguide/anal-cancer-what-is-key-statistics. Accessed February 28, 2016.
National Cancer Institute Surveillance, Epidemiology, and End Results Program. Available at: http://seer.cancer.gov/statfacts/html/anus.html. Accessed February 28, 2016.
Schiffman M, Kjaer SK (2003) Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31:14–19
Zbar AP, Fenger C, Efron J et al (2002) The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma. Int J Color Dis 17:203–215
Apgar BS, Kittendorf AL, Bettcher CM et al (2009) Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. Am Fam Physician 80:147–155
Gervaz P, Hahnloser D, Wolff BG et al (2004) Molecular biology of squamous cell carcinoma of the anus: a comparison of HIV-positive and HIV-negative patients. J Gastrointest Surg 8:1024–1030 discussion 31
Jay N, Berry JM, Hogeboom CJ et al (1997) Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon rectum 40:919–928
Tate DR, Anderson RJ (2002) Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis. Am J Obstet Gynecol 186:880–882
National Cancer Institute Surveillance, Epidemiology, and End Results Program. Available at: http://seer.cancer.gov/statfacts/html/cervix.html. Accessed February 28, 2016.
Stier EA, Goldstone SE, Berry JM et al (2008) Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr 47:56–61
Scholefield JH, Ogunbiyi OA, Smith JH et al (1994) Treatment of anal intraepithelial neoplasia. Br J Surg 81:1238–1240
Lyons M, Francis N, Allen-Mersh TG (1999) Treatment of grade 3 anal intraepithelial neoplasia by complete anal mucosal excision without fecal diversion: report of a case. Dis Colon rectum 42:1342–1344
Pehoushek J, Smith KJ (2001) Imiquimod and 5 % fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man. Arch Dermatol 137:14–16
Hamdan KA, Tait IS, Nadeau V et al (2003) Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Dis Colon rectum 46:1555–1559
Lacey CJ (2005) Therapy for genital human papillomavirus-related disease. J Clin Virol 32(Suppl 1):S82–S90
Goldstone SE, Johnstone AA, Moshier EL (2014) Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer. Dis Colon rectum 57:316–323
Pineda CE, Berry JM, Jay N et al (2008) High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon rectum 51:829–835 35-7
Goldstone RN, Goldstone AB, Russ J, Goldstone SE (2011) Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men. Dis Colon rectum 54:1284–1292
Marks DK, Goldstone SE (2012) Electrocautery ablation of high-grade anal squamous intraepithelial lesions in HIV-negative and HIV-positive men who have sex with men. J Acquir Immune Defic Syndr 59:259–265
Weis SE, Vecino I, Pogoda JM, Susa JS (2012) Treatment of high-grade anal intraepithelial neoplasia with infrared coagulation in a primary care population of HIV-infected men and women. Dis Colon rectum 55:1236–1243
Richel O, de Vries HJ, van Noesel CJ et al (2013) Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. Lancet Oncol 14:346–353
Basu KK, Pick B, Bale R et al (2002) Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium. Gut 51:776–780
Shaheen NJ, Sharma P, Overholt BF et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360:2277–2288
American Gastroenterological Association, Spechler SJ, Sharma P et al (2011) American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 140:1084–1091
ASGE Standards of Practice Committee, Evans JA, Early DS et al (2012) The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc 76:1087–1094
Wang KK, Tian JM, Gorospe E et al (2012) Medical and endoscopic management of high-grade dysplasia in Barrett’s esophagus. Dis Esophagus 25:349–355
Lyday WD, Corbett FS, Kuperman DA et al (2010) Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 42:272–278
Orman ES, Li N, Shaheen NJ (2013) Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol 11:1245–1255
Bulsiewicz WJ, Kim HP, Dellon ES et al (2013) Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett’s esophagus. Clin Gastroenterol Hepatol 11:636–642
Phoa KN, Pouw RE, van Vilsteren FG et al (2013) Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 145:96–104
Small AJ, Araujo JL, Leggett CL et al (2015) Radiofrequency ablation is associated with decreased neoplastic progression in patients with Barrett’s esophagus and confirmed low-grade dysplasia. Gastroenterology 149:567–576 e3; quiz e13-4
Wolf WA, Pasricha S, Cotton C et al (2015) Incidence of esophageal adenocarcinoma and causes of mortality after radiofrequency ablation of Barrett’s esophagus. Gastroenterology 149:1752–1761 e1
Shaheen NJ, Falk GW, Iyer PG et al (2016) ACG clinical guideline: diagnosis and Management of Barrett’s esophagus. Am J Gastroenterol 111:30–50 quiz 1
Smulian AG, Moore DM, Robertson JC, Kralovic SM (2014) Phase I study demonstrates safety and tolerability of radiofrequency ablation (RFA) of the anal mucosa. HIV Clin Trials 15:36–44
Darragh TM, Colgan TJ, Thomas Cox J et al (2013) The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 32:76–115
Sirera G, Videla S, Pinol M et al (2013) Long-term effectiveness of infrared coagulation for the treatment of anal intraepithelial neoplasia grades 2 and 3 in HIV-infected men and women. AIDS 27:951–959
Swedish KA, Lee EQ, Goldstone SE (2011) The changing picture of high-grade anal intraepithelial neoplasia in men who have sex with men: the effects of 10 years of experience performing high-resolution anoscopy. Dis Colon rectum 54:1003–1007
Silvera R, Gaisa MM, Goldstone SE (2014) Random biopsy during high-resolution anoscopy increases diagnosis of anal high-grade squamous intraepithelial lesions. J Acquir Immune Defic Syndr 65:65–71
Acknowledgments
The authors thank the patients who volunteered for the study and the site study personnel and pathologists at Quest Diagnostics and Enzo Clinical Laboratories for their assistance in interpreting histology.
Author/coauthor contributions
Author contributions include conception and study design (SEG, SRH, SD), study recruitment and data acquisition (SEG), study analysis and interpretation of the data (SEG, RNG, TMD, AvZ), drafting of the article (SEG, RNG), critical revision of the article for important intellectual content (SEG, RNG, SRH, SD, TMD, AvZ), and final approval of the article (SEG, RNG, SRH, SD, TMD, AvZ).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Conflict of interest
The study was sponsored and funded by Medtronic (Sunnyvale, CA). Medtronic provided medical writing assistance and statistical analysis support. SEG and TMD (or their institutions) received research support from Medtronic to conduct this trial. TMD has received supplies from Hologic. SRH and SD are employees and stockholders of Medtronic. SEG received consulting fees from Medtronic.
Rights and permissions
About this article
Cite this article
Goldstone, R.N., Hasan, S.R., Drury, S. et al. A trial of radiofrequency ablation for anal intraepithelial neoplasia. Int J Colorectal Dis 32, 357–365 (2017). https://doi.org/10.1007/s00384-016-2679-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-016-2679-2